These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 29403000

  • 1. The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents.
    Griebel G, Stemmelin J, Lopez-Grancha M, Fauchey V, Slowinski F, Pichat P, Dargazanli G, Abouabdellah A, Cohen C, Bergis OE.
    Sci Rep; 2018 Feb 05; 8(1):2416. PubMed ID: 29403000
    [Abstract] [Full Text] [Related]

  • 2. Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures.
    Smaga I, Bystrowska B, Gawliński D, Pomierny B, Stankowicz P, Filip M.
    Neurotox Res; 2014 Aug 05; 26(2):190-206. PubMed ID: 24652522
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system.
    Okine BN, Norris LM, Woodhams S, Burston J, Patel A, Alexander SP, Barrett DA, Kendall DA, Bennett AJ, Chapman V.
    Br J Pharmacol; 2012 Oct 05; 167(3):627-40. PubMed ID: 22595021
    [Abstract] [Full Text] [Related]

  • 5. Impaired anandamide/palmitoylethanolamide signaling in hippocampal glutamatergic neurons alters synaptic plasticity, learning, and emotional responses.
    Zimmermann T, Bartsch JC, Beer A, Lomazzo E, Guggenhuber S, Lange MD, Bindila L, Pape HC, Lutz B.
    Neuropsychopharmacology; 2019 Jul 05; 44(8):1377-1388. PubMed ID: 30532004
    [Abstract] [Full Text] [Related]

  • 6. Amygdala FAAH and anandamide: mediating protection and recovery from stress.
    Gunduz-Cinar O, Hill MN, McEwen BS, Holmes A.
    Trends Pharmacol Sci; 2013 Nov 05; 34(11):637-44. PubMed ID: 24325918
    [Abstract] [Full Text] [Related]

  • 7. Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide.
    Fowler CJ, Jonsson KO, Tiger G.
    Biochem Pharmacol; 2001 Sep 01; 62(5):517-26. PubMed ID: 11585048
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
    Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D.
    J Pharmacol Exp Ther; 2005 Apr 01; 313(1):352-8. PubMed ID: 15579492
    [Abstract] [Full Text] [Related]

  • 10. Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase.
    Karbarz MJ, Luo L, Chang L, Tham CS, Palmer JA, Wilson SJ, Wennerholm ML, Brown SM, Scott BP, Apodaca RL, Keith JM, Wu J, Breitenbucher JG, Chaplan SR, Webb M.
    Anesth Analg; 2009 Jan 01; 108(1):316-29. PubMed ID: 19095868
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of fatty acid amides in the carrageenan-induced paw edema model.
    Wise LE, Cannavacciulo R, Cravatt BF, Martin BF, Lichtman AH.
    Neuropharmacology; 2008 Jan 01; 54(1):181-8. PubMed ID: 17675189
    [Abstract] [Full Text] [Related]

  • 12. Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety.
    Danandeh A, Vozella V, Lim J, Oveisi F, Ramirez GL, Mears D, Wynn G, Piomelli D.
    Psychopharmacology (Berl); 2018 Nov 01; 235(11):3211-3221. PubMed ID: 30251159
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
    Di Marzo V, Melck D, Orlando P, Bisogno T, Zagoory O, Bifulco M, Vogel Z, De Petrocellis L.
    Biochem J; 2001 Aug 15; 358(Pt 1):249-55. PubMed ID: 11485574
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antidepressant-like effects of pharmacological inhibition of FAAH activity in socially isolated female rats.
    Carnevali L, Statello R, Vacondio F, Ferlenghi F, Spadoni G, Rivara S, Mor M, Sgoifo A.
    Eur Neuropsychopharmacol; 2020 Mar 15; 32():77-87. PubMed ID: 31948828
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain.
    Jiang HX, Ke BW, Liu J, Ma G, Hai KR, Gong DY, Yang Z, Zhou C.
    Anesth Analg; 2019 Aug 15; 129(2):587-597. PubMed ID: 29863609
    [Abstract] [Full Text] [Related]

  • 19. Effects of endocannabinoid and endovanilloid systems on aversive memory extinction.
    Laricchiuta D, Centonze D, Petrosini L.
    Behav Brain Res; 2013 Nov 01; 256():101-7. PubMed ID: 23948212
    [Abstract] [Full Text] [Related]

  • 20. Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications.
    Bisogno T, De Petrocellis L, Di Marzo V.
    Curr Pharm Des; 2002 Nov 01; 8(7):533-47. PubMed ID: 11945157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.